BioCorRx Inc.
BICX
$0.41
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 147.45% | -28.94% | -1.32% | 31.97% | -20.25% |
| Total Depreciation and Amortization | -608.89% | 409.94% | 251.50% | 3.90% | -74.11% |
| Total Amortization of Deferred Charges | -44.65% | -43.94% | -67.11% | -43.44% | -1.50% |
| Total Other Non-Cash Items | -239.92% | 65.12% | -55.09% | 46.71% | 713.23% |
| Change in Net Operating Assets | -369.07% | -128.33% | 48.27% | -191.13% | 338.03% |
| Cash from Operations | -242.92% | -77.45% | 16.72% | -103.00% | 53.69% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -39.26% | -73.51% | 260.67% | 68.42% | -21.14% |
| Total Debt Repaid | -27,775.00% | 94.68% | 0.00% | -1,750.00% | -500.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 108.71% | 131.98% | 261.82% | 66.63% | -24.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -268.71% | 2,218.07% | 194.61% | -277.99% | 196.38% |